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Coronary artery bypass surgery (CABG) is considered
to be the most preferable therapeutic option for
unprotected left main coronary artery disease. However,
with the advancement of percutaneous stenting
technique, the paradigm for left main percutaneous
coronary intervention (PCI), coronary disease therapy
appears to be changing. Gruntzig in 1978 first published
the performance of percutaneous coronary angioplasty
(PCA) in left main coronary disease.1 At present, the
main indication for stent implantation in unprotected left
main coronary disease include situations in which
immediate re-vascularization is required such as acute
myocardial infarction and cardiogenic shock or the
presence of other serious co-morbidities which make
the more invasive surgery unsuitable. The main aim of
the present study was to describe the results of
percutaneous stenting for unprotected left main
coronary artery disease with elaboration of its
associated high risk profile and clinical outcome.
The study was conducted at the Aga Khan University
Hospital. All patients undergoing percutaneous coronary
intervention for unprotected left main coronary disease
between January 2003 to December 2007, were
included. All those patients were evaluated by cardio-
thoracic surgery prior to percutaneous intervention but
were deemed unfit for surgery due to unstable hemo-
dynamics, underlying severe left ventricular dysfunction
and associated serious co-morbid conditions. A detailed
review of the medical records and follow-up of
concerned patients was done. Patients with protected
left main disease having a patent graft to left anterior
descending coronary artery or left circumflex coronary
artery and patients who had received thrombolytic
therapy in the preceding 24 hours were excluded.
Descriptive statistics were presented as mean
± standard deviation, median with range for quantitative
variables and number (percentages) for qualitative
variables. All analyses were performed in SPSS 16.0 for
Windows.
A total of 9 patients were included. Five patients were
male and mean age of the patients was 70.1±11.9
years. Five patients had Diabetes (55.6%) while 8
patients were hypertensive (88.9%). Six (66.7%)
patients were in cardiogenic shock. Three patients had
ongoing ST elevation myocardial infarction, 3 had non-
ST elevation myocardial infarction and 5 patients were in
acute pulmonary edema. Six patients had three-vessel
disease and 3 patients had two-vessel disease. One
patient underwent PCI of the right coronary artery
(RCA) and one of the LCx along with left main stenting.
The site of left main coronary stenosis, type of
interventional technique employed, procedural results,
in-hospital and long-term outcome of these patients are
detailed in Table I. Drug eluting stents (DES) were used
in 6 patients just to decrease the chances of instent
restenosis in left main as compared to BMS (bare metal
stent). POBA (percutaneous only balloon angioplasty)
was used in one patient only because he twice had
cardiac arrest on table and had a poor chance of
survival. Four patients expired during hospital stay while
5 patients were alive at the time of discharge. All the 4
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ABSTRACT
Percutaneous coronary intervention for unprotected left main coronary artery disease is potentially an important
intervention in surgically unstable patients. A detailed review of medical record and visual analysis of coronary angiography
and PCI procedure was undertaken. The study was conducted at the Aga Khan University Hospital, from January 2003 to
December 2007. Patients included in the study had unprotected > 70% left main stenosis with ongoing ischemia,
considered unsuitable for surgical revascularization. A total of 9 patients were included with a mean age of 70.1 years. Six
patients had cardiogenic shock. Eight patients had bifurcation lesion. Simultaneous kissing stenting technique was used
in 4 patients. There were 4 in-hospital deaths while 5 patients were alive at discharge. All 4 patients who expired had
cardiogenic shock. Four patients were alive at a mean follow-up of 17 months. PCI turned out to be an alternative
therapeutic option for unprotected left main coronary artery disease when surgery is declined.
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patients who died had cardiogenic shock, thereby
reflecting the high mortality associated with this clinical
presentation. Of the 5 patients who were alive at the
time of discharge, 4 patients were alive at a mean follow-
up of 17 months with no reported “major adverse
cardiac events” (MACE). One patient died after 2
months hospital discharge due to massive intra-
abdominal haemorrhage as she was on oral anti-
coagulant therapy for a prosthetic mitral valve.
One of the largest series published by O’Keefe et al. in
1989 demonstrated the technical feasibility of
percutaneous management of left main coronary artery
disease but it had 64%, 3-year mortality rate.2
Unprotected Left Main Trunk Intervention Multi-Center
Assessment (ULTIMA) registry enrolled 279 patients
with unprotected LMCA disease who were managed by
percutaneous coronary re-vascularization (69% bare
metal stent), mortality at a one-year follow-up was 40%
in high-risk patients while it was 3.5% in low-risk patient
cohorts. Twenty percent of these patients were in
cardiogenic shock at the time of  PCI and 50% had an
IABP (Intra-aortic balloon pump).3 Seung et al. in a
recently published large registry compared unprotected
left main stenting (1102 patients) with CABG (1138
patients) on propensity analysis score. In the overall
matched cohort, there was no significant difference
between stenting and CABG groups in the risk of death
or of composite outcome.4 This study patients
comprised a very high risk group. Six patients were in
cardiogenic shock and 6 patients had acute myocardial
infarction. Five patients required intra aortic balloon
counter pulsation for unstable hemodynamics. Left main
distal bifurcation lesion is more frequently encountered
in clinical practice than ostial disease. In this limited
series of patients, 8 patients had distal bifurcation
lesions while only one patient had ostial left main
disease reflecting the presence of  high risk lesions for
stenting. In this study, all the 4 patients who died during
hospital stay were in cardiogenic shock. All those deaths
happened within 36 hours suggesting that if these
patients survived during the initial period of this serious
illness then they had a good chance of survival to
discharge. At a mean follow-up of 17.75 months
(ranging from 6 to 27 months), 4 patients were still alive
while one patient died due to a non-cardiac cause.
Currently, left main PCI is not a very commonly used
procedure. In a registry of 7752 patients undergoing PCI
in 140 centres over 6 months in 2005, only 110 patients
had LMS (left main stenting) stenting equivalent to 2%.5
However, the recently completed 2 years data of syntax
trial showed that PCI of unprotected left main had MACE
equal to the CABG except for high re-vascularization
rate with PCI. 
In the current perspective, CABG is still considered the
first choice in left main disease. Percutaneous stenting
is an alternative therapeutic option for patients with
unprotected left main disease who are not suitable for
surgical re-vascularization. It is associated with
favourable in-hospital and long-term outcomes in
patients without cardiogenic shock. However, more
prospective randomized clinical trials are needed to
better define the role of percutaneous stenting in left
main coronary disease.
REFERENCES
1. Gruntzig A. Transluminal dilatation of coronary-artery stenosis.
Lancet 1978; 1:263.
2. O'Keefe JH Jr, Hartzler GO, Rutherford BD, McConahay DR,
Johnson WL, Giorgi LV, et al. Left main coronary angioplasty:
early and late results of 127 acute and elective procedures.
Am J Cardiol 1989; 64:144-7.
3. Tan WA, Tamai H, Park SJ, Plokker HW, Nobuyoshi M, Suzuki T,
et al. ULTIMA Investigators. Long-term clinical outcomes after
unprotected left main trunk percutaneous re-vascularization in
279 patients. Circulation 2001; 104:1609-14. Comment in:
Circulation 2002; 105:e85. 
4. Seung KB, Park DW, Kim YH, Lee SW, Lee CW, Hong MK, et al.
Stents versus coronary-artery bypass grafting for left main
coronary artery disease. N Engl J Med 2008; 358:1781-92. Epub
2008 Mar 31. Comment in: p.1851-3. 
5. Beohar N, Davidson CJ, Kip KE, Goodreau L, Vlachos A,
Meyers SN, et al. Outcomes and complications associated with
off-label and untested use of drug-eluting stents. JAMA 2007;
297:1992-2000. Comment in: p. 2028-30.
288 Journal of the College of Physicians and Surgeons Pakistan  2010, Vol. 20 (4): 287-288
Hafeez Ahmed, Javed Majid Tai and Sajid Dhakam
Table I: Type of LM disease, stenting technique and clinical
outcomes.
Variables n (%)
Technique
SKS 04 (44.4)
LM –> LAD 03 (33.3)
LM –> LCx 01 (11.1)
KB 01 (11.1)
Stent
DES 06 (66.7)
BMS 02 (22.2)
POBA only 01 (11.1)
Post procedural TIMI flow
0 1 (11.1)
I 1 (11.1)
III 07 (77.8)
LM Ostial 1 (11.1)
LM Shaft 0
LM Distal 08 (88.9)
Dissection 02 (22.2)
Haziness 02 (22.2)
No re-flow 02 (22.2)
In-Hospital death 04 (44.4)
Death in patients with cardiogenic shock (06) 04 (66.66)
Death in patients without cardiogenic shock (03) 0 (0)
Discharged alive 05 (55.6)
Survival at 17 months of follow-up 04 (44.4)
SKS = Simultaneous Kissing Stenting technique;  DES = Drug eluting stent; 
TIMI flow = Thrombolysis in Myocardial Infarction flow;   KB = Kissing ballooning only; 
LM = left main;   LAD = left anterior descending artery; LCx = left circumflex artery;
POBA = Percutaneous only balloon angioplasty.
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